News

Call for greater innovation in HIV diagnostics at IAS 2015

Tracy Parish

23 July, 2015

News  cd4 test at ias 2015 510 x 288

VISITECT® CD4 stand at IAS 2015 conference in Canada. Image courtesy of Omega Diagnostics Group PLC.

Greater innovation in HIV diagnostics is urgently needed if the world hopes to achieve the UNAID’s global target of ’90-90-90’ access to antiretroviral therapy by 2020.

That’s the message coming from the world’s leading HIV scientific experts at this week’s 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS2015) in Vancouver, Canada.

The UNAIDS’ ambitious global treatment target was declared at the AIDS 2014 Conference in Melbourne, requiring 90 per cent of people living with HIV knowing their status, 90 per cent of people diagnosed with HIV to be on treatment, and 90 per cent of people on treatment to have suppressed viral load.

Burnet’s breakthrough low-cost point-of-care HIV diagnostic, VISITECT® CD4 has been noted in several IAS 2015 conference presentations and is being showcased by licensing partners Omega Diagnostics Group PLC. The VISITECT® CD4 diagnostic test is currently undergoing field trials.

At IAS 2015, UNAIDS is reporting that global experts have focused on three key diagnostic challenges: ensuring timely diagnosis of HIV among children, rapidly increasing knowledge of HIV status among adults living with HIV and scaling up essential viral load testing.

UNAIDS says the new international guidelines on HIV testing services, launched by the World Health Organization (WHO) this week, indicate that WHO envisages widespread access to self-testing as an important component of a comprehensive HIV testing effort. The new WHO guidelines emphasise the importance of moving testing access closer to communities, including recommending steps to enable lay workers to administer HIV tests.

Find out more about the VISITECT® CD4 test.

Contact Details

For more information in relation to this news article, please contact:

Associate Professor David Anderson

Deputy Director (Partnerships), Burnet Institute; Co-Head, Global Health Diagnostics Development

Telephone

+61392822239

Email

david.anderson@burnet.edu.au

Subscribe to News

Subscribe to receive our latest news: